2007
Utility of sweat patch testing for drug use monitoring in outpatient treatment for opiate dependence
Chawarski MC, Fiellin DA, O'Connor PG, Bernard M, Schottenfeld RS. Utility of sweat patch testing for drug use monitoring in outpatient treatment for opiate dependence. Journal Of Substance Use And Addiction Treatment 2007, 33: 411-415. PMID: 17512157, PMCID: PMC3632440, DOI: 10.1016/j.jsat.2007.03.004.Peer-Reviewed Original ResearchMeSH KeywordsBuprenorphineHumansOpioid-Related DisordersPatch TestsPatient Acceptance of Health CareSensitivity and SpecificitySubstance Abuse DetectionSweatConceptsOutpatient clinical settingPatch testingDrug useClinical settingSweat testingEfficacy of buprenorphinePrimary care settingRandomized clinical trialsSelf-reported drug usePositive urine resultsSweat test resultsDrug use monitoringUrine toxicologyOpioid dependenceOutpatient treatmentUrine testingClinical trialsCare settingsOpiate useOpiate dependenceUrine resultsStudy participantsLevel of agreementToxicology testsLow acceptability
1998
Assessment of HIV Risk
Chawarski M, Pakes J, Schottenfeld R. Assessment of HIV Risk. Journal Of Addictive Diseases 1998, 17: 49-59. PMID: 9848031, DOI: 10.1300/j069v17n04_05.Peer-Reviewed Original ResearchMeSH KeywordsHIV InfectionsHumansPredictive Value of TestsReproducibility of ResultsRisk AssessmentRisk-TakingSensitivity and SpecificitySubstance-Related DisordersSurveys and Questionnaires